Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats

[1]  J. Changeux,et al.  Reduced antinociception in mice lacking neuronal nicotinic receptor subunits , 1999, Nature.

[2]  S. Arneric,et al.  Role of the Nucleus Raphe Magnus in Antinociception Produced by ABT-594: Immediate Early Gene Responses Possibly Linked to Neuronal Nicotinic Acetylcholine Receptors on Serotonergic Neurons , 1998, The Journal of Neuroscience.

[3]  S. Arneric,et al.  ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization. , 1998, The Journal of pharmacology and experimental therapeutics.

[4]  S. Arneric,et al.  Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. , 1998, European journal of pharmacology.

[5]  D. Donnelly-roberts,et al.  Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. , 1998, Journal of medicinal chemistry.

[6]  D. Donnelly-roberts,et al.  Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. , 1998, Science.

[7]  E. Strauss.  New Nonopioid Painkiller Shows Promise in Animal Tests , 1998, Science.

[8]  S. Fletcher,et al.  Antinociceptive and toxic effects of (+)‐epibatidine oxalate attributable to nicotinic agonist activity , 1994, British journal of pharmacology.

[9]  D. Donnelly-roberts,et al.  (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[10]  J. Eckman,et al.  Epibatidine is a nicotinic analgesic. , 1993, European journal of pharmacology.

[11]  C. Kornetsky,et al.  Nicotine and brain-stimulation reward: Interactions with morphine, amphetamine and pimozide , 1993, Pharmacology Biochemistry and Behavior.

[12]  D. Bradley.  Frog venom cocktail yields a one-handed painkiller. , 1993, Science.

[13]  S. Fletcher,et al.  The synthesis of (+)- and (–)-epibatidine , 1993 .

[14]  J. Lake,et al.  Rodent model of nicotine abstinence syndrome , 1992, Pharmacology Biochemistry and Behavior.

[15]  L. Pannell,et al.  Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an ecuadoran poison frog , 1992 .

[16]  S. Rogers,et al.  A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.

[17]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[18]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[19]  H. Sugano,et al.  A Convenient Method of Synthesizing Protected α-Amino-γ-butyrolactones , 1973 .

[20]  H. Sugano,et al.  A NOVEL SYNTHESIS OF OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACID , 1973 .

[21]  UchidaShogo,et al.  NEW DOUBLE SALT OF SULFAMIC ACID AND POTASSIUM SULFATE , 1972 .